reason report
volum driven on-board us margin remain
pressur pt
bottom line decent quarter view
publish updat model account result
updat guidanc quarter overal ok believ
deliv anoth quarter low qualiti earn quarter
adj ep beat consensu estim driven
lower tax rate provid benefit lower-end
guidanc rais estim reflect
lower-than expect tax rate quarter us retail result
bolster addit store margin remain
pressur due higher mix specialti possibl
mix store retail result mix
divis oper incom miss estim wholesal
result beat estim seem highli focus market share
rx volum growth despit rx fill comp store flat y/i
agre volum import howev continu believ
reduc rate plan pbm order gain share
result gross margin percentag revenu usa retail remain
pressur maintain mp pt decreas
integr on-track bolster us retail divis top-
line margin disappoint last quarter disclos
acquir store today re-affirmed
transfer three distribut center relat inventori
still expect begin asset expect fulli
integr end part integr process
close total store intend close
previous guid deliv annual save
end addit store help bolster us retail
divis quarter gener revenu y/
beat leerink/consensu drove total
rx volum y/i ahead estim
howev rx fill compar store flat y/i
well behind well adj gm om
segment disappoint rel model adj gm segment
impact higher mix specialti advers impact gm
bp adj om trail estim repres
y/i declin bp disappoint adj om divis
due part higher cost mix store
net debt total capit
price-to-earnings lt ep growth
ep
compani inform leerink partner llc research
ep exclud acquisition-rel cost acquisition-rel amort non-recur item includ lifo adjust revenu billion
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
hub model pilot continu evolv seek
deliv true omni channel experi prepar remark
manag discuss develop healthcar servic within
store larg focu may analyst day link
manag remind audienc recent announc trial
hum/op bring full primari care clinic store
well expand on-going pilot lab corp view
pilot aim creat true omni channel experi
like respons propos op -aet mp front door
healthcar strategi look forward transpar disclosur
manag vision store format updat
transform process
low-end guidanc increas adj ep guidanc rais
prior rang new rang impli
adj ep growth y/i last quarter guidanc
rais midpoint due tax reform believ
like tax driver increas well adj tax
came quarter lower model
tweak estim increas ep estim
reflect quarter adj ep increas
ep decreas ep
decreas reflect weak comp us retail
largest global pharmaci led retail pharmaceut wholesal
organ world walgreen us drugstor chain largest pharmaci chain
us store count industri size improv purchas power brand-nam
recognit improv store traffic overal volum health plan self-insur
employ seek reduc medic cost via restrict network believ walgreen in-stor
clinic may provid attract altern plan walgreen nation presenc
also attract mani plan view provid larg corpor broad access
view gener launch wave next sever year posit impact
bottom line walgreen balanc reward custom loyalti program help lower
print ad cost bring individu market benefit recent work increas wba
privat brand product share mix well new front-end merchandis strategi
posit impact same-stor sale profit addit walgreen recent deal
allianc boot offer promis long-term synergi global
growth back lost share esrx network disput
although grow accept narrow network remain risk walgreen provid
health plan wide array servic includ infus specialti dispens lab servic
hospit partnership primari care servic case walgreen also earli
mover advantag purchas jv boot deal walgreen
pbm may advantag case make retail chain payer agnost
mani strength believ retail channel face signific challeng
includ increasingli competit environ seek creat
restrict prefer narrow network deal effort captur store traffic volum
medacorp specialist check indic retail rate reduc
case keep pressur retail gross margin
furthermor on-going gener launch believ wave
larg behind us becom increasingli difficult show gross margin expans
retail also believ transact posit busi stock howev
deterior lose share even though deal approv investor
sentiment stock name appear low lastli threat amazon entri
pharmaci servic space continu weigh stock believ
retail exposur sinc own pbm given risk
concern rate share market perform
next month expect share trade ep
would put stock price multipl reflect on-going reimburs
pressur minim accret slowdown volum growth headwind
intern busi believ posit win share
becom extens network vast array clinic capabl believ new
manag team take step reduc overal cost increas sale higher margin
front-stor product posit retail rate remain signific pressur
brand gener price also headwind becom aggress
overal respons market also overhang unlik abat time soon
given challeng concern rate share market perform
competit high retail pharmaci industri highli competit contract
pbm manufactur also competit walgreen compet chain
independ drug store well mail order prescript provid groceri store on-line
pharmaci pharmaceut vendor chang competit landscap
impact rx volum neg impact compani sale earn
macroeconom regulatori climat uncertainti continu econom slowdown
 would bode poorli sinc above-averag unemploy rate drive lower
level consum spend would decreas prescript drug util regulatori
environ also fair amount uncertainti time impact variou
healthcar reform provis could materi impact wba oper nation emphasi
reduc healthcar cost could also spawn reimburs pressur new way contain
healthcar cost devis implement
intern exposur execut risk walgreen merger allianc boot increas
exposur intern market increas currenc exposur regulatori risk
wba partnership uniqu approach contract distribut
compani fail execut vision accret could expect
season time cost adjust swing result front-end sale
prescript sale compon season sale also lumpi depend
holiday line calendar sever cold cough flu season
magnitud compani lifo provis also fluctuat given quarter depend
inventori level sale inflat also swing result contribut earn
miss beat
amazon entri amazon may seek disrupt pharmaci market enter
retail market buy build contract pbm news topic pose
headlin risk share amazon could formid competitor mail cash pay
incom statement model fiscal year end august mm
sale
revenu
revenu
gross profit sg spread bp
equiti earn ab
share allianc boot associ
sale acquisit adjust
revenu
revenu
net earn attr nci
revenu
total non-gaap adjust tax
compani report leerink partner llc estim
revenu
revenu
equiti earn allianc boot
sale acquisit adjust
compani report leerink partner llc estim
revenu
revenu
revenu
revenu
adjust equiti earn
elimin unalloc
sale
compani report leerink partner llc estim
sale
equiti earn allianc boot
share allianc boot associ
previous held equiti interest
tax earn equiti method invest
net incom attrib non-control interest
net incom attrib walgreen
gain previous held equiti interest
increas decreas fair market valu warrant
partial releas capit loss valuat allow
loss sale busi
gain previous held equiti interest
increas decreas fair market valu warrant
partial releas capit loss valuat allow
compani report leerink partner llc estim
